News About: Pharm. Industry
Concerns mounting over new drug reform
The government’s plan to implement its revised volume forecast plan for a drug starting next year has triggered concerns from the domestic pharmaceutical community.
Under the plan, drug manufacturers and the Natio...
Drugmakers, wholesalers stuck in fight over pharmacy’s financial cost
The dispute between drug manufacturers and wholesalers over the latter’s demand that the contentious financial cost given to pharmacies should be guaranteed by drug companies in addition to wholesalers’ profit margin....
Tension rises over doctors’ boycott
Without a doubt, the tension between doctors and pharmaceutical firms and doctors is culminating this month as the Seoul Central District Court will make its ruling on 10 doctors involved in kickbacks offered by Dong-...
Daewoong calls for civil group’s clarification over Ursa dispute
Daewoong Pharmaceutical has launched its offensive against the Korean Pharmacists for Democratic Society (KPDS) over the latter’s false efficacy claim that Ursa (ursodeoxycholic acid) is nothing but a digestive agent,...
Korean drug firm signs record license deal
Korean biopharmaceutical company Medytox said Thursday that it has signed a deal to exclusively license a neurotoxin to Procter & Gamble Pharmaceuticals (P&GP) that could be worth US$$362 million.
Under the deal, A...
Drugmakers to scale back pharmacy business
A growing number of pharmaceutical firms are seeking to curtail their direct transactions with pharmacies in a bid to boost their faltering earnings.
The main reason drug firms has opted for such tactics lies in th...
MBC issues correction over Ursa
The broadcaster MBC on Wednesday issued the correction over Daewoong Pharm’s Ursa, thehe best-selling hepatic function medicine, denying that Ursa is nearly similar to a digestive, not a drug to combat fatigue, which ...
Ildong to distribute Smiths Medical’s medical devices in Korea
Ildong Pharmaceutical and Smiths Medical, a leading global medical device manufacturer, has signed a distribution agreement for the exclusive sale of Smiths Medical’s main medical devices in Korea, such as Jelco Intui...
Mundipharma CEO promoted to general managerMundipharma International on Sept. 17 said it promoted Mundipharm Korea president Lee Jong-ho to general manager in seven Southeast countries as well as Korea.
The promotion,...
|
Drug watchdog suspends production of Dongwha’s anti-diarrheal medicationsKorea‘s drug watchdog said Tuesday that it has imposed a ban on the production of Dong-A Pharmaceutical’s anti-diarrheal medication Lacterol, which has been in three different d...
|
